Strata Skin Sciences (FRA:E2O) FFO


FRA:E2O Strata Skin Sciences Inc FRA:E2O
38 GF Score
Price €3.76
GF Value €58.84
! 5 Warning Signs
View Full Analysis

What is Strata Skin Sciences FFO?

FFO (Funds from operations) only applies to REITs.

FRA:E2O
38GF Score
Strata Skin Sciences Inc FRA:E2O
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Strata Skin Sciences (FRA:E2O) Overvalued in 2026?

Based on GuruFocus' analysis, Strata Skin Sciences stock appears to be undervalued. The current stock price of €3.76 is trading 93.6% below its estimated GF Value™ of €58.84.

Key valuation signals for FRA:E2O:

  • FFO:
  • GF Value™: €58.84 vs. price of €3.76 (93.6% below fair value)
  • GF Score™: 38/100 with 5 warning signs

No single metric tells the full story. See the FRA:E2O stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Strata Skin Sciences Business Description

Other Exchanges SSKN:USA
Address 5 Walnut Grove Drive, Suite 140, Horsham, PA, USA, 19044
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo, and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver, and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.
38GF Score

Get the complete analysis for FRA:E2O

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.76
Price
€58.84
GF Value